| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |